Match each clinical research scenario or study objective with the most appropriate statistical measure of association or impact.
- A public health initiative aims to quantify the proportion of cardiovascular disease cases in the general community that could be theoretically eliminated if trans-fat consumption were completely eradicated.Population attributable risk percent (PAR%)
- A retrospective study identifies patients with newly diagnosed bladder cancer and age-matched healthy volunteers, comparing their prior history of artificial sweetener consumption.Odds ratio (OR)
- A randomized controlled trial calculates the simple difference in the incidence rates of ischemic stroke between patients receiving a novel anticoagulant and those receiving standard therapy.Absolute risk reduction (ARR)
- A systematic review calculates the number of patients who must receive a newly approved immunosuppressive agent, rather than placebo, to cause one additional case of severe opportunistic infection.Number needed to harm (NNH)
- An observational study follows a large cohort of healthy factory workers over ten years to compare the incidence of chronic obstructive pulmonary disease in those exposed to silica dust versus those who are unexposed.Relative risk (RR)
Answer
Public health proportion -> PAR%; Case-control study -> OR; Difference in incidence -> ARR; Additional adverse event -> NNH; Cohort study incidence -> RR.
Each scenario perfectly aligns with the fundamental definition and use-case of its corresponding statistical measure. Case-control studies necessitate the use of Odds Ratios, while cohort studies allow for the calculation of Relative Risk. Absolute Risk Reduction is defined by the difference in incidence rates, and Number Needed to Harm translates that difference into patient counts for adverse events. Finally, Population Attributable Risk Percent specifically measures the potential public health impact of eliminating an exposure in a broader community.
Step-by-Step Solution
Key Concept
Appropriate selection of biostatistical measures of association based on study design and clinical objectives.